Skip to content

Transvaginal natural orifice transluminal endoscopic sacro-uerospinal ligament suspension versus sacrospinal ligament fixation in pelvic organ prolapse: a prospective randomized controlled trials

Transvaginal natural orifice transluminal endoscopic sacro-uerospinal ligament suspension versus sacrospinal ligament fixation in pelvic organ prolapse: a prospective randomized controlled trials

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100052927
Enrollment
Unknown
Registered
2021-11-06
Start date
2021-11-10
Completion date
Unknown
Last updated
2022-08-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pelvic organ prolapse

Interventions

Group A1:vNOTES S-ULS
Group A2:SSLF
Group B1:vNTOES S-ULS+colporrhaphy
Group B2:SSLF+colporrhaphy

Sponsors

Obstetrics and Gynecology Hospital of Fudan University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
40 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Symptomatic POP-Q >=II grade, or asymptomatic POP-Q >=III grade pelvic organ prolapse patients; 2. More than 40 years old, have children, and have sexual needs; 3. Refuse conservative treatment or fail conservative treatment; 4. Refuse mesh implantation for pelvic floor reconstruction surgery; 5. The patients can be followed up for 2 years after operation.

Exclusion criteria

Exclusion criteria: 1. A history of pelvic radiotherapy; 2. There is a history of transvaginal mesh treatment for prolapse; 3. Women with fertility requirements; pregnant or breastfeeding; 4. Chronic pelvic pain caused by pelvic floor muscle spasm was found in the basic state examination; 5. Long-term use of steroid hormones with immune diseases; 6. Past history of pelvic malignancy or current suspicion of malignancy.

Design outcomes

Primary

MeasureTime frame
Uterine Prolapse POPQ Score;Pelvic floor quality of life score;Sexual life quality PISQ-12;

Secondary

MeasureTime frame
operation time;estimated blood loss;postoperative hospital stay;hospital cost;postoperative fever rate;

Countries

China

Contacts

Public ContactChen Yisong

Obstetrics and Gynecology Hospital Affiliated to Fudan University

417573113@qq.com+86 13311725060

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026